IDSA, APHA Call on White House to Reverse Handling of COVID-19 Data
Organizations believe the CDC is best positioned to collect, analyze and distribute information that is vital to research and response efforts.
Study: Too Little Lopinavir in Lungs to Treat COVID-19
Although plasma levels of lopinavir increase as its metabolism is inhibited by inflammation in COVID-19, levels in the lungs remain subtherapeutic.
Mothers with COVID-19 Unlikely to Pass it to Their Newborns
A small study reports no mother-to-newborn transmission of virus.
Interpreting the Oxford, Moderna COVID-19 Vaccine Data
Angela Rasmussen, PhD, explains how preliminary findings for both candidates define their potential for preventing or lessening coronavirus.
Effective Decontamination Methods Critical to Preserving N95 Mask Integrity
Some ways of decontaminating N-95 respirator masks can degrade mask integrity, according to the authors of a recent study.
Benefits of Routine Childhood Vaccination Versus Risk of Coronavirus Infection
A benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
In Utero Zika Exposure Leads to a Range of Abnormalities
Microcephaly is not the only manifestation of developmental problems after antenatal exposure to the Zika virus. And even infants who appear normal at birth may display differences as they grow.
The Relationship Characteristics of Pediatric Multisystem Inflammatory Disease and COVID-19
More COVID-19 patients were hospitalized with MIS-C in April than in March, a study finds.
A World Without Antibiotics? Why Patients Should Care About Resistance
Dr. Pol Vandenbroucke describes the individual and collective risks associated with rising antibiotic resistance.
The Stakes of Antibiotic Stewardship
Dr. Pol Vandenbroucke talks about what makes antibiotic stewardship so important to clinicians and researchers.
Providers: Face Masks Outside Hospital Settings, Counseling Patients on COVID-19
In this second installment of his interview, Howard Koh, MD, MPH, discusses the importance of providers and health care workers wearing face masks during their interactions with patients.
US Government Buying 100 Million Doses of COVID-19 Vaccine
HHS is securing Pfizer and BioNTech’s BNT162 vaccine as soon as FDA approves.
One-Third of Older Americans Have Received a Shingles Vaccine
Shingles vaccination rates have risen from 6.7% in 2008 to 34.5% in 2018 among American adults 60 and older.
Clinics Have Capacity to Help Families Catch Up on Vaccinations During COVID
Many families fell behind on vaccines during the pandemic, but a study finds most clinics are available to schedule make-up appointments.
Ebola Outbreak Reaches 60 Patients in Mbandaka, DRC
How might this new outbreak in Mbandaka differ from the recent outbreak in Kivu, a more conflict-prone region of the DRC?
FDA Approves OraRisk Coronavirus PCR Test
The test is not FDA approved, but is instead authorized for emergency use in the context of the SARS-CoV-2 pandemic.
Probiotic Use Among Older Care Home Residents Does Not Reduce Antibiotic Use
A common combination of probiotics showed no benefits for reducing antibiotic administration in older adults in care homes, according to a study led by Oxford University investigators.
Calling Upon Florida and the Nation to Require Face Masks
A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.
Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Isolation Precautions and COVID-19: How Long is Enough?
Should we be reconsidering the length of time patients are isolated?
Loss of Life From Antibiotic Resistance May Surpass Cancer By 2050
Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.
COVID-19 Investigational Therapy Approved for Phase 2 Study
The FDA clears way for next phase for abivertinib to treat hospitalized patients.
Adenovirus Vector Vaccine Shows Promise Against SARS-CoV-2
A single injection of the Ad5-vectored COVID-19 vaccine induced specific immune responses to the spike glycoprotein at day 28.
Mortality Rates in Hospitalized COVID-19 Patients on Dexamethasone Lower VS Usual Care
This was seen in patients who were receiving either invasive mechanical ventilation or oxygen.
UK Orders Large Quantity of Pfizer mRNA Vaccine
The development of BNT162 is based on BioNTech’s mRNA platform; the vaccine will then be produced using Pfizer’s vaccine manufacturing capacities.
University of Oxford COVID-19 Vaccine Induces Strong Immune Responses
New data shows the ChAdOx1 nCoV-19 vaccine candidate induces T cell response within 14 days, and antibody response within 28 days.
COVID-19 Antibody Test Receives EUA
Luminex Receives FDA Emergency Use Authorization for its xMAP SARS-CoV-2 Multi-Antigen IgG Assay.
FDA Grants Emergency Authorization for COVID-19 Specimen Pooling
Quest Diagnostics will now able to efficiently test larger groups of specimen among persons from low-coronavirus risk areas.
CDC Survey Reveals Telling Information on COVID-19 Outpatients
Results highlight burden of disease and potential issues associated with contact tracing.
Catching the Flu Increases Risk for Invasive Pneumococcal Disease
Contracting influenza increased the risk for invasive pneumococcal disease in a study conducted across 3 countries.
